NCT00503841 2019-04-30
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Terminated
Barbara Ann Karmanos Cancer Institute
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center